INTRODUCTION AND OBJECTIVES:
The use of new/novel oral anticoagulants (NOACs) continues to increase and Urologists are faced with increasing numbers of patients in their practice using these agents. Although general guidelines directing the management of these medications in the perioperative period exist for open and endoscopic procedures, no consensus exists for those patients being considered for shock wave lithotripsy (SWL). In order to gauge current practice, we developed and sent a survey to the endourological community.
METHODS: A web-based survey was sent to all current Endourological Society members. Members were asked 10 questions regarding their current practice in dealing with patients using NOACs and who might be candidates for SWL. Respondents were specifically asked whether being on a NOAC would be considered a contraindication to SWL, or if SWL was to be performed, when the agent would be discontinued preoperatively and resumed postoperatively. Respondents were also queried on who managed the NOAC discontinuation and resumption.
RESULTS: There were 165 respondents from 37 countries, with the largest cohort responding from North America (43%). (87.8%) of society members had been in practice for 5 years or more, with (70%) being in an academic practice. The vast majority (92.73%) provided SWL treatments in their institutions, while only (53.37%) would consider offering SWL to patients taking NOACs. The decision on when to stop NOACs prior to SWL, was made by (36.65%) of urologists although the majority (56%) consulted internal medicine/cardiology for their input. The majority of urologists (64.2%) handled the resumption of the NOACs after SWL by themselves. There appeared to be great variability in the number of days prior to SWL were NOACs stopped, and when they were resumed Post treatment.
CONCLUSIONS: Somewhat surprisingly, over half of surveyed endourologists do not even offer SWL to patients taking NOACs. For those patients who are treated with SWL there appears to be a lack of consensus among endourologists on what is the optimal duration of NOAC cessation, suggesting a need to establish evidence-based guidance to optimize outcomes.
Source of Funding: none

PD26-10 REGIONAL VARIATION IN RATES OF SWL UTILIZATION AMONG PATIENTS WITH NEPHROLITHIASIS
Gina Tundo*, Vernon Pais, Lebanon, NH INTRODUCTION AND OBJECTIVES: Nephrolithiasis is rising in prevalence and continues to pose an increasing financial burden on society. Common management options for stones include watchful waiting, percutaneous stone removal, ureteroscopy and shock wave lithotripsy, with the latter two comprising the majority of interventions for stones in the US. When multiple treatment options exist, effective care is heralded by equal utilization rates in disparate locations. Conversely, if variation is identified, this may be secondary to unwarranted variation, potentially driven by either supply-sensitive or preference-sensitive care. Responsible health care spending dictates identification of variation in surgical utilization as a first step in unravelling and then addressing underlying sources of potentially unwarranted variation. Variation in the utilization of SWL has been suspected but not comprehensively evaluated in the United States.
METHODS: Utilizing the full 100% Medicare dataset from the year 2014, we identified all patients with the diagnosis of a renal stone within the previously defined and validated 306 hospital referral regions (HRR's) of the US. Among beneficiaries with the diagnosis of a renal stone, we then assessed the rate of any type of surgical management of the stone, and then specifically the rate of use of SWL, both on a national level and by HRR. Both crude rates and rates adjusted by age, sex and race were generated.
RESULTS: In 2014 there were a total of 806,652 included Medicare beneficiaries with a diagnosis of a renal stone. Nationally, the rate of any surgical intervention was 71.34/1,000. The HRR with the lowest rate of surgical intervention was 31.67/1,000 while that with the highest was 131.02/1,000, representing an approximately 4-fold variation in the rate of all surgical management.
For SWL, the national rate of utilization was 45.48/1,000 patients with kidney stones. The HRR with the lowest rate of SWL utilization was 9.24/1,000 while that with the highest was 105.80/1,000, representing a greater than 11-fold regional variation in SWL utilization among those with stones.
CONCLUSIONS: In this all-inclusive population of Medicare beneficiaries with a diagnosis of a renal stone, there is dramatic variation in the rate of SWL utilization. Although this may reflect overutilization of SWL in some centers and underutilization in others, these findings clearly suggest that the probability of having SWL as opposed to any other management option for a stone may depend heavily upon the hospital to which one is referred. Whether this is due to supply-sensitive factors including the availability of a lithotripter or number of urologists on staff, or preference-sensitive factors including the surgeon's preferred treatment, warrants further investigation. Future efforts to standardize treatment algorithms and develop shared decision-making models may reduce unwarranted variation in the care of patients with kidney stones.
Source of Funding: none
PD26-11 QUALITY INDICATORS FOR SHOCKWAVE LITHOTRIPSY IN THE STATE OF MICHIGAN: ARE WE FOLLOWING THE GUIDELINES?
Casey Dauw*, Kavya Swarna, Tae Kim, Jaya Telang, Ann Arbor, MI; David Leavitt, Mazen Abdelhady, Detroit, MI; Elena Gimenez, Ann Arbor, MI; Karla Witzke, Midland, MI; John Hollingsworth, Khurshid Ghani, Ann Arbor, MI INTRODUCTION AND OBJECTIVES: Recent guidelines from the American Urological Association (AUA) provides a clinical framework for the surgical management of patients with kidney stones. The extent to which these guidelines are followed in clinical practice for patients undergoing shockwave lithotripsy (SWL) has not been studied. To better understand quality indicators for SWL, we assessed adherence to AUA recommendations for the treatment of renal stones using data from a statewide clinical registry.
METHODS: We used the Michigan Urologic Surgery Improvement Collaborative Reducing Operative Complications for Kidney Stones (MUSIC ROCKS) registry to understand SWL use in the state of Michigan. This prospectively maintained registry includes data from community and academic practices and contains detailed clinical and operative data for patients undergoing SWL and ureteroscopy. We identified all patients undergoing SWL from 2016 to 2018. In accordance with AUA guidelines, we evaluated practice patterns in relation to
